HRTX Heron Therapeutics, Inc.
$0.30▲ +0.27%
Healthcare
Other
After hours
$0.31▲ +2.82%
Oct 27, 5:55 PM ET
Volume 1.10M
Avg Volume (10D) 2.03M
Key Metrics & Fundamentals
Market Cap
$57.24M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.26 - 1.58
% vs 50 MA
-8.30%
% vs 200 MA
-58.06%
RSI-14
41.0
MACD Histogram
-0.0100
Beta (1Y vs SPY)
1.69
Free Cash Flow
-$2.35M
Gross Rev
$37.67M
Gross Profit
$26.09M
EBITDA
-$1.59M
COGS
$11.57M
Operating Exp
$28.14M
Operating Income
-$2.04M
EBIT
-$2.04M
Pretax Income
-$5.49M
Net Income
-$5.49M
EPS (Diluted)
-0.03
Price & Volume History
Loading chart…
Recent News
Heron Therapeutics to Report Third Quarter 2026 Financial Results on Monday, November 9, 2026
GlobeNewswire · Oct 26, 2026 8:09 PM ET
--HC Wainwright Downgrades Heron Therapeutics to Neutral From Buy
MT Newswires · Aug 11, 2026 7:30 AM ET
Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ...
GuruFocus.com · Aug 10, 2026 5:01 PM ET
Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook
InvestorsHub · Aug 10, 2026 11:05 AM ET
Heron Therapeutics Q2 Earnings Call Highlights
MarketBeat · Aug 10, 2026 10:04 AM ET
Heron Therapeutics (HRTX) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 10, 2026 9:10 AM ET
Heron Therapeutics: Q2 Earnings Snapshot
Associated Press · Aug 10, 2026 8:06 AM ET
BioCryst Pharmaceuticals (BCRX) Tops Q2 Earnings and Revenue Estimates
Zacks · Aug 5, 2026 9:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See HRTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.